Benaroya Research Institute
The Benaroya Research Institute in Seattle is recruiting faculty investigators in immunology to study immune system functions in health and disease. The institute offers a collaborative environment, advanced core facilities, and access to clinical and translational research opportunities, focusing on autoimmune and immune-mediated diseases.
Headquarters
Seattle, Washington, United States
Company Size
201-500 employees
Founded
1956
Benaroya Research Institute (BRI) is a Seattle-based nonprofit biomedical research institute dedicated to understanding the immune system and developing new treatments for autoimmune, immune-mediated and inflammatory diseases. Research is organized into Centers of Discovery—Fundamental, Translational, Interventional and Systems Immunology—combining basic science, bioinformatics and clinical translation. BRI’s multidisciplinary faculty advance biomarkers, therapies and clinical trials through partnerships with hospitals, industry and patient communities. The institute focuses on moving discoveries from the lab to the clinic to improve diagnosis, prevention and treatment.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Benaroya Research Institute.
Postdoctoral Researcher
La Jolla Institute for Immunology
Associate Director, Translational Medicine (Immunology)
BeOne Medicines
Associate Professor or Full Professor without Tenure, Department of Pediatrics, Division of Immunology, Center for Immunity and Immunotherapies (CIIT)
University of Washington
Postdoctoral Researcher
UT Southwestern Medical Center
Postdoctoral Scientist
Cedars-Sinai
In Vivo Scientist
AstraZeneca